Evidence map›Paper›PMID 32979053›Full record

ArticleCellular and molecular life sciences : CMLS2021

The transport pathway in the ABCG2 protein and its regulation revealed by molecular dynamics simulations.

Tamás Nagy, Ágota Tóth, Ágnes Telbisz, Balázs Sarkadi, Hedvig Tordai, Attila Tordai, Tamás Hegedűs

Open access · hybridAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Differential dynamics and direct interaction of bound ligands with lipids in multidrug transporter ABCG2.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  12. Article
  13. Two Important Anticancer Mechanisms of Natural and Synthetic Chalcones.International journal of molecular sciences · 2022
    Review
  14. Review
  15. Article
  16. Ins and outs of AlphaFold2 transmembrane protein structure predictions.Cellular and molecular life sciences : CMLS · 2022
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Tamás NagyDepartment of Biophysics and Radiation Biology, Semmelweis University, Tuzolto u. 37-47, 1094, Budapest, Hungary.
Ágota TóthDepartment of Biophysics and Radiation Biology, Semmelweis University, Tuzolto u. 37-47, 1094, Budapest, Hungary.ORCID https://orcid.org/0000-0003-1376-5291
Ágnes TelbiszInstitute of Enzymology, Research Centre for Natural Sciences, Magyar Tudosok krt. 2, 1117, Budapest, Hungary.ORCID https://orcid.org/0000-0003-0972-4606
Balázs SarkadiDepartment of Biophysics and Radiation Biology, Semmelweis University, Tuzolto u. 37-47, 1094, Budapest, Hungary.
Hedvig TordaiDepartment of Biophysics and Radiation Biology, Semmelweis University, Tuzolto u. 37-47, 1094, Budapest, Hungary.
Attila TordaiDepartment of Transfusion Medicine, Semmelweis University, Nagyvarad ter 4, 1089, Budapest, Hungary.
Tamás HegedűsDepartment of Biophysics and Radiation Biology, Semmelweis University, Tuzolto u. 37-47, 1094, Budapest, Hungary. hegedus@hegelab.org.ORCID http://orcid.org/0000-0002-5195-749X
Semmelweis University · HUInstitute of Molecular Life Sciences · HU

Funding

Nemzeti Kutatási Fejlesztési és Innovációs Hivatal K127961Semmelweis Egyetem Science and Innovation Fund 2019
6 · The paper itself

Abstract

Atomic-level structural insight on the human ABCG2 membrane protein, a pharmacologically important transporter, has been recently revealed by several key papers. In spite of the wealth of structural data, the pathway of transmembrane movement for the large variety of structurally different ABCG2 substrates and the physiological lipid regulation of the transporter has not been elucidated. The complex molecular dynamics simulations presented here may provide a breakthrough in understanding the steps of the substrate transport process and its regulation by cholesterol. Our analysis revealed drug binding cavities other than the central binding site and delineated a putative dynamic transport pathway for substrates with variable structures. We found that membrane cholesterol accelerated drug transport by promoting the closure of cytoplasmic protein regions. Since ABCG2 is present in all major biological barriers and drug-metabolizing organs, influences the pharmacokinetics of numerous clinically applied drugs, and plays a key role in uric acid extrusion, this information may significantly promote a reliable prediction of clinically important substrate characteristics and drug-drug interactions.

Indexed as

Molecular Dynamics SimulationATP Binding Cassette Transporter, Subfamily G, Member 2Binding SitesBiological TransportCholesterolHumansIrinotecanMembrane LipidsMutationNeoplasm ProteinsProtein BindingProtein DomainsABCG2 protein, humanATP Binding Cassette Transporter, Subfamily G, Member 2CholesterolIrinotecanMembrane LipidsNeoplasm ProteinsABCG2Cholesterol regulationMolecular dynamicsMultidrug transport

Identifiers

PMID32979053
PMCPMC7966132
OpenAlexW3089281398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.